Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Omada Health vs Woodwork

Omada Health
Graded #435

Lower grade

vs+17.6
Woodwork
Graded #72

Higher grade

The verdict

Woodwork takes it — 73.2/100 to 55.6/100.

Woodwork grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Woodwork is a men's health telehealth platform built by Grindr that offers compounded GLP-1 weight-loss medications alongside ED care, with a focus on serving gay and queer men.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWoodwork +33
45
78
Dose & formulationWoodwork +35
40
75
Clinical oversightWoodwork +5
77
82
Labs & monitoringWoodwork +13
61
74
FulfillmentWoodwork +4
62
66
Contract termsOmada Health +14
55
41
Omada Health · left barWoodwork · right bar

The numbers

MetricOmada HealthWoodwork
WeighScore55.6/10073.2/100
GradeCC
Scorecard rank#435#72
SemaglutideNot disclosed$127/mo (starting dose, compounded)
TirzepatideNot disclosed$199/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Omada Health

Graded #435 · C

Strengths

  • Added GLP-1 prescribing and medication management in late 2025
  • Clinicians trained in obesity care, available in all 50 states
  • Behavioral support wrapped before, during and after treatment
  • GLP-1 Flex Care adds a cash-pay medication pathway in 2026
  • Publicly traded, evidence-based virtual care platform

Where it loses points

  • Core program distributed via employers and health plans, limited cash-pay
  • GLP-1 prescribing is a recent addition still scaling
  • GLP-1 Flex Care only rolling out to employers later in 2026
  • No transparent published price for the core member program
Woodwork

Graded #72 · C

Strengths

  • Low transparent pricing: compounded semaglutide from $127/month, tirzepatide from $199/month, microdose $134/month
  • Compounded semaglutide offered as injection or oral tablet
  • No separate consult or membership fees
  • Free shipping, included lab work, and 1-on-1 care coaching
  • HSA and FSA eligible; bundles a free Grindr Unlimited subscription

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Cash-pay only — no insurance billing
  • States served are not listed publicly
  • No compounding pharmacy partner named and no LegitScript badge shown
  • Weight loss is secondary to the platform's men's-health/ED focus

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard